AU5513796A - Remedy for acquired immunodeficiency syndrome - Google Patents

Remedy for acquired immunodeficiency syndrome

Info

Publication number
AU5513796A
AU5513796A AU55137/96A AU5513796A AU5513796A AU 5513796 A AU5513796 A AU 5513796A AU 55137/96 A AU55137/96 A AU 55137/96A AU 5513796 A AU5513796 A AU 5513796A AU 5513796 A AU5513796 A AU 5513796A
Authority
AU
Australia
Prior art keywords
remedy
acquired immunodeficiency
immunodeficiency syndrome
syndrome
acquired
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU55137/96A
Other languages
English (en)
Inventor
Masanori Baba
Hiroyuki Masayasu
Ikuro Muruyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Publication of AU5513796A publication Critical patent/AU5513796A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D293/00—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms
    • C07D293/10—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU55137/96A 1995-04-25 1996-04-24 Remedy for acquired immunodeficiency syndrome Abandoned AU5513796A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP7-99273 1995-04-25
JP9927395 1995-04-25
PCT/JP1996/001106 WO1996033712A1 (fr) 1995-04-25 1996-04-24 Remede pour lutter contre le syndrome de l'immunodeficience acquise

Publications (1)

Publication Number Publication Date
AU5513796A true AU5513796A (en) 1996-11-18

Family

ID=14243078

Family Applications (1)

Application Number Title Priority Date Filing Date
AU55137/96A Abandoned AU5513796A (en) 1995-04-25 1996-04-24 Remedy for acquired immunodeficiency syndrome

Country Status (2)

Country Link
AU (1) AU5513796A (fr)
WO (1) WO1996033712A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000058281A1 (fr) 1999-03-31 2000-10-05 Daiichi Pharmaceutical Co., Ltd. Substrats pour thioredoxine reductase
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3027075A1 (de) * 1980-07-17 1982-02-18 A. Nattermann & Cie GmbH, 5000 Köln Benzisoselenazolone, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3027073C2 (de) * 1980-07-17 1985-03-07 A. Nattermann & Cie GmbH, 5000 Köln Pharmazeutische Präparate, enthaltend 2-Phenyl-1,2-benzisoselenazol-3(2H)-on
DE3616923A1 (de) * 1986-05-20 1987-11-26 Nattermann A & Cie Neue pharmazeutische verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-on
DE3638124C2 (de) * 1986-11-08 1996-09-05 Nattermann A & Cie Neue pharmazeutische Verwendung von Ebselen
JPH01131113A (ja) * 1987-08-27 1989-05-24 Dai Ichi Seiyaku Co Ltd 脳障害治療剤
JP2548223B2 (ja) * 1987-08-27 1996-10-30 第一製薬株式会社 腎臓疾患治療剤
JP2710633B2 (ja) * 1987-08-28 1998-02-10 第一製薬株式会社 心臓疾患治療剤
JP2577016B2 (ja) * 1987-11-18 1997-01-29 第一製薬株式会社 消化管疾患治療剤
JPH01135718A (ja) * 1987-11-18 1989-05-29 A Nattermann & Cie Gmbh 放射線障害治療剤
JP2548267B2 (ja) * 1988-01-06 1996-10-30 第一製薬株式会社 感染症用剤
EP0622076B1 (fr) * 1992-01-17 1997-04-02 Daiichi Pharmaceutical Co., Ltd. Inhibiteur de restenose apres arterioplastie coronarienne percutanee

Also Published As

Publication number Publication date
WO1996033712A1 (fr) 1996-10-31

Similar Documents

Publication Publication Date Title
AUPN449295A0 (en) Radioprotectors
AU4780896A (en) Core-board
AU6000496A (en) Phenylpyridazinones
AU4900096A (en) Task chair
AU1030997A (en) Taphane
AU6904896A (en) Pharmaceutical compounds
AU4580096A (en) Forms stacker
AU5147496A (en) Fucopeptides
AU3389395A (en) Interferometer
AU5593896A (en) Benzisothiazolyl-substituted aminomethylchromans
AU7570296A (en) 25-hydroxy-16-ene-26,27-bishomo-cholecalciferols
AU5500196A (en) Anti-transpirants
AU4382896A (en) Acetylimidazobenzodiazepines
AU5013796A (en) Wireclamp
AU5513796A (en) Remedy for acquired immunodeficiency syndrome
AU7546096A (en) Pharmaceutical compounds
AU5107096A (en) Haemodialyser
AU4395796A (en) Etherification process
AU1682395A (en) Speckle depixelator
AU6366496A (en) Document
AU6733996A (en) Staurosporine analogues
AU1205497A (en) Vaccine component
AU2161897A (en) Helicopter-airplane
AU5878096A (en) Fasciotome
AU2609095A (en) Compartmentalizer